Clinical Trial to Evaluate CG2001 in Chinese Adult Male Participants With Androgenetic Alopecia

PHASE2RecruitingINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

December 5, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Male Pattern of Hair Loss, Androgenic AlopeciaAndrogenetic Alopecia (AGA)
Interventions
DRUG

minoxidil + finasteride

topical foam: 5%minoxidil+0.075%finasteride

DRUG

minoxidil + finasteride

topical foam: 5%minoxidil+0.1%finasteride

DRUG

Placebo foam

Topical placebo foam

Trial Locations (8)

Unknown

COMPLETED

Beijing Tongren Hospital Affiliated to Capital Medical University, Beijing

COMPLETED

China-Japan Friendship Hospital, Beijing

COMPLETED

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

COMPLETED

Xiangya Hospital of Central South University, Changsha

COMPLETED

Jiangxi Provincial Dermatology Hospital, Nanchang

COMPLETED

Huashan Hospital Affiliated to Fudan University, Shanghai

COMPLETED

Hangzhou First People's Hospital, Hangzhou

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Beijing Dayspring Pharmaceutical Technology Co., Ltd

INDUSTRY